کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
443352 692708 2014 10 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Molecular dynamics analysis of the interaction between the human BCL6 BTB domain and its SMRT, NcoR and BCOR corepressors: The quest for a consensus dynamic pharmacophore
موضوعات مرتبط
مهندسی و علوم پایه شیمی شیمی تئوریک و عملی
پیش نمایش صفحه اول مقاله
Molecular dynamics analysis of the interaction between the human BCL6 BTB domain and its SMRT, NcoR and BCOR corepressors: The quest for a consensus dynamic pharmacophore
چکیده انگلیسی


• We have performed 100 ns MD of the complexes between BCL6 and SMRT, NcoR or BCOR.
• A structure for the BCL6-NcoR complex is proposed from homology modeling.
• We propose a consensus pharmacophore that can be divided into two parts.
• This pharmacophore can be used to find new inhibitor compounds.
• We propose a codrug administration as a novel strategy to inhibit BCL6.

Targeting the BCL6 protein is a promising therapeutic strategy for the treatment of B cell lymphomas. One approach to treat these diseases consists of finding drug candidates able to disrupt the interactions established between BCL6 and its corepressors. Thus, this work presents a thorough comparative analysis of the interactions between the BCL6 BTB (bric-a-brac tramtrack broad complex) protein domain and its SMRT, NcoR and BCOR corepressor BBDs (BCL6 binding domain) through molecular dynamics. Moreover, a theoretical structure is presented and checked for the BCL6BTB–NcoRBBD complex. Considering the BBDs to be composed of 17 amino acids, our analyses show the region involving residues 4–15 of these 17 to play a main role in the protein–corepressor interactions. Particularly SER11 seems to have a high relevance as it establishes specific bonds with BCL6BTB and is one of the only two residues sequence equivalent for the three studied corepressors. From this study, 14 pharmacophoric points have been proposed divided in two groups which coincide with residues 4–11 and 11–15, being SER11 a hinge point. This finding suggests the possibility of searching for 2 small molecule inhibitors, mimicking 8 and 7 pharmacophoric points, respectively, which could incorporate a hydrogen donor pharmacophoric point mimicking SER11 in any or both molecules. In short, the present work aims to contribute further knowledge in the modeling of drugs mimicking BCL6BTB–corepressor complexes.

Figure optionsDownload high-quality image (331 K)Download as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Molecular Graphics and Modelling - Volume 50, May 2014, Pages 142–151
نویسندگان
, , , , ,